The Dutch guidelines presented emphasize a critical safety rule: the ABO blood group of a patient must be determined on at least two separate blood samples, and there must be no discrepancies between the results. If the two samples yield different ABO types, this is a major red flag indicating a serious error. In such a case, the transfusion laboratory must NOT issue any blood for that patient until the discrepancy is fully resolved. The cause must be investigated immediately. Possible causes include mislabeled samples (the most dangerous, implying two different patients), sample mix-up in the lab, an error in testing one of the samples, or a rare clinical condition like recent stem cell transplant. Patient safety depends on resolving this before any transfusion.

Break down complex topics into smaller, manageable chunks for easier recall.

Zambia

• Naomi Miselo – 31 pts

• Visual Pathway Lesions
• Positive and Negative Symptoms
• Hallucinations and Delusions
• Antipsychotic Medications
• Emergency: Environmental Emergencies